Bharat Biotech to use ViroVax's adjuvant in Covid vaccine

Bharat Biotech has teamed up with ViroVax to use the US scientific research firm ’s adjuvant for boosting the immune response and providing long-lasting immunity to its novel vaccine candidate Covaxin, which has entered phase-2 human trials.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news